|
|
 |
|
 |
Richard T. Clark
Chairman of the Board, President and Chief Executive Officer, Merck & Co., Inc. Merck Director since 2005. |
|
 |
Johnnetta B. Cole, Ph.D
President Emerita of Spelman College and Bennett College for Women. Merck Director since 1994. |
|
 |
Thomas H. Glocer
Chief Executive Officer, Reuters Group PLC (global news and information company). Director, Reuters Group PLC. Merck Director since November 2007. |
|
 |
Steven F. Goldstone
Retired; Chairman and Chief Executive Officer, RJR Nabisco, Inc.; Managing Partner, Silver Spring Group. Non-Executive Chairman, ConAgra Foods, Inc. Director, Trane Inc. (formerly American Standard Companies, Inc.) and Greenhill & Co., Inc. (investment firm). Merck Director since 2007. |
|
 |
William B. Harrison, Jr.,
Retired; Chairman of the Board, JPMorgan Chase & Co. (financial services). Director, Cousins Properties Incorporated. Merck Director since 1999.
|
|
 |
Harry R. Jacobson, M.D.
Vice Chancellor, Health Affairs, Vanderbilt University Medical Center. Director, CeleNova BioSciences, Inc., HealthGate Data Corporation, Ingram Industries, Inc. and Kinetic Concepts, Inc. Merck Director since December 2007.
|
|
 |
William N. Kelley, M.D.
Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine. Director, Advanced Bio-Surfaces, Inc., Beckman Coulter, Inc., GenVec, Inc., and Polymedix, Inc. Merck Director since 1992. |
|
 |
Rochelle B. Lazarus
Chairman and Chief Executive Officer, Ogilvy & Mather Worldwide (advertising and marketing communications). Director, General Electric. Merck Director since 2004. |
|
 |
Thomas E. Shenk, Ph.D.
Elkins Professor, Department of Molecular Biology, Princeton University. Director, Cell Genesys, Inc. and CV Therapeutics, Inc. Merck Director since 2001. |
|
 |
Anne M. Tatlock
Retired; Chairman of the Board and Chief Executive Officer, Fiduciary Trust Company International (global asset management services). Director, Fortune Brands, Inc. and Franklin Resources, Inc. Merck Director since 2000. |
|
 |
Samuel O. Thier, M.D.
Professor of Medicine and Health Care Policy, Emeritus, Harvard Medical School. Director, Charles River Laboratories, Inc. Merck Director since 1994. |
|
 |
Wendell P. Weeks
President and Chief Executive Officer, Corning Incorporated (technology company in telecommunications, information display and advanced materials industries). Director, Corning Incorporated. Merck Director since 2004. |
|
 |
Peter C. Wendell
Managing Director, Sierra Ventures ( technology-oriented venture capital firm). Chairman, Princeton University Investment Company. Merck Director since 2003. |
|
|
|
|
|
|
|
|
